Showing all 2 results

  • Clopidogrel+Aspirin Tablets, Clopidogrel Aspirin Tablets 75/75, Clopidogrel 75mg and Aspirin 150mg, Co-Plavix Generic, DuoPlavin Generic, Ecosprin Gold Generic, Deplatt-A Generic, Dual Antiplatelet Therapy (DAPT), Post-Stent Medicine, Heart Attack Prevention FDC, Blood Thinner Tablet, Antithrombotic Drug, ACS Treatment, CAS 113665-84-2 (Clopidogrel), CAS 50-78-2 (Aspirin), Healthy Inc Cardiac Medicines, WHO GMP Certified Tablet Unit, Contract Manufacturing Clopidogrel Aspirin, Third Party Manufacturing Pharma, Hospital Bulk Supply Cardiology, Ministry of Health Tender, Government Tender Pharma Supplier, NGO Medicine Procurement, Cath Lab Supply, HS Code 30049099, Clopidogrel Aspirin Supplier Africa, DAPT Exporter Philippines, Clopidogrel Bisulfate USP BP, Medicine Export to Africa, Pharmaceutical Drop Shipper, B2B Pharma Marketplace, Medicine Export to LATAM, Tabletas de Clopidogrel y Aspirina, Tabletas Antiplaquetarias, Comprimés de Clopidogrel et Aspirine, Thérapie Antiplaquettaire Double, Medicamento Trombosis, Tratamiento Post-Stent, Comprimidos de Clopidogrel e Aspirina, Medicamentos Cardiovasculares, Клопидогрел и Аспирин таблетки, Антиагреганты, Лечение инфаркта, أقراص كلوبيدوجريل وأسبرين, مميع للدم, دواء القلب, クロピドグレル・アスピリン配合錠, 抗血小板薬, ステント血栓症予防, 氯吡格雷阿司匹林片, 双重抗血小板药, 支架术后药, Clopilet-A Generic, Clavix-AS Generic, Global Pharmaceutical Suppliers Africa LATAM
    In Stock
    Add to wishlist
    Compare
    Quick View
    , ,

    Clopidogrel, Aspirin Tablets Clopidogrel, Aspirin Tablets

    Free

    A Clopidogrel + Aspirin tablet is a dual antiplatelet therapy (DAPT) used primarily to prevent serious cardiovascular events like heart attacks and strokes

    Read more
  • Placeholder
    In Stock
    Add to wishlist
    Compare
    Quick View
    ,

    Ticagrelor Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the highly sensitive active pharmaceutical ingredient across all global climate zones.

    Active IngredientStrengthPrimary Clinical Use
    Ticagrelor INN/Ph.Eur.90 mgAcute & Post-ACS: Standard twice-daily dose for the first 12 months following a heart attack or stent placement.
    Ticagrelor INN/Ph.Eur.60 mgExtended Maintenance: Long-term prophylaxis for high-risk patients continuing therapy beyond the initial 12-month period.
    ExcipientsMannitol / Dibasic Calcium Phosphate / Sodium Starch Glycolate / HypromelloseDiluent / Superdisintegrant / Film Coating (Engineered for immediate, highly predictable gastric dissolution)
    Read more